Skip to content
Prime Point Network

The Zimbabwean Government Declines ‘Lopsided’ US Healthcare Assistance Package Due to Data Fears

Medical aid image
The proposed US funding would have supported programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has rejected a major American health deal worth 367 million US dollars (272 million pounds) over five years due to the United States' demand for confidential data.

This move was revealed following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".

A government representative has since explained that the United States was requesting genetic material for scientific study and commercial purposes but was not willing to share the resulting advantages from any future medical innovations.

"We will now turn to the challenging and unfortunate process of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has urged more dialogue to reach a deal acceptable to all parties so the nation's critical HIV programme can proceed.

Wider Background

This rejection comes after a similar case in neighbouring Kenya, where a high court halted a related deal with the US after legal challenges were filed about the security of citizens' health data.

After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

USAID had overseen assistance for the US government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and accountability.

Based on statements, 16 African countries have so far signed these new agreements, constituting more than $18.3bn in committed funds.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"It is our view this collaboration would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"Our nation was requested to provide its biological resources and data indefinitely, without any equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.

"Put simply, our nation would provide the basic resources for scientific discovery with no assurance that the end products would be accessible to our people if a new health crisis arise."

National Interest and Global Health

He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining frameworks previously set up through the international organization.

The spokesperson cited its Pandemic Benefit-Sharing system created to deal with future global health emergencies.

"This mechanism is intended to ensure that when a country provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," he added.

"We encourage ongoing discussions with our American counterparts on how subsequent collaboration might be structured in a manner that honours the sovereignty and interests of each country."

Health Experts Reaction

A leading public health body said it acknowledged the government's concerns, but suggested that negotiations must proceed since much of the country's Aids initiatives were funded by international support.

"In cases where specific concerns arise, including those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group said.

The halted deal underscores the complex debate between accepting crucial foreign assistance and safeguarding local interests in an increasingly data-driven world.

Written by

Heidi Wright

Liam de Vries is a seasoned business strategist and networker with 15 years of experience.

Prime Point Network

Type to search articles.